ShareholdingJun 30, 2026, 08:33 AM
Moleculin Biotech Raises $2.7M from Warrant Exercises
AI Summary
Moleculin Biotech, Inc. announced that warrants to purchase 1,361,500 shares of its common stock have been exercised, generating approximately $2.7 million in gross proceeds. This transaction increased the company's common stock outstanding to 7,065,000 shares as of June 29, 2026. Additionally, the company updated its corporate presentation, which is now available on its website.
Key Highlights
- Warrants to purchase 1,361,500 shares of common stock were exercised.
- Generated approximately $2.7 million in gross proceeds for the company.
- Common stock outstanding reached 7,065,000 shares as of June 29, 2026.
- Company posted an updated corporate presentation on its website.
- The corporate presentation is dated June 2026.
Price Impact
More from MBRX